Secondary leukemia responsive to retinoic acid with abnormal localization of RARalpha protein: a report of two cases.
Leone
G
G
Sica
S
S
Ortu La Barbera
E
E
Testa
U
U
Riccioni
R
R
Labbaye
C
C
Peschle
C
C
Zollino
M
M
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D018168:Receptors, Retinoic Acid / Q000378:metabolism*; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin / Q000627:therapeutic use*
D000970:Antineoplastic Agents; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin